Verkaik N - Search Results

1

Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T.

Ruigrok EAM, Tamborino G, de Blois E, Roobol SJ, Verkaik N, De Saint-Hubert M, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: verkaik n. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3956-3957. doi: 10.1007/s00259-022-05845-2. Eur J Nucl Med Mol Imaging. 2022. PMID: 35614268 Free PMC article. No abstract available.

2

Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region.

Verkaik NS, van Steenbrugge GJ, van Weerden WM, Bussemakers MJ, van der Kwast TH. Verkaik NS, et al. Lab Invest. 2000 Aug;80(8):1291-8. doi: 10.1038/labinvest.3780137. Lab Invest. 2000. PMID: 10950120 Free article.

3

Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response.

Feijtel D, Doeswijk GN, Verkaik NS, Haeck JC, Chicco D, Angotti C, Konijnenberg MW, de Jong M, Nonnekens J. Feijtel D, et al. Among authors: verkaik ns. Theranostics. 2021 Jan 1;11(2):491-505. doi: 10.7150/thno.51215. eCollection 2021. Theranostics. 2021. PMID: 33391488 Free PMC article.

4

A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair.

Pulver EM, Mukherjee C, van de Kamp G, Roobol SJ, Rother MB, van der Gulden H, de Bruijn R, Lattanzio MV, van der Burg E, Drenth AP, Verkaik NS, Hahn K, Klarenbeek S, de Korte-Grimmerink R, van de Ven M, Pritchard CEJ, Huijbers IJ, Xia B, van Gent DC, Essers J, van Attikum H, Ray Chaudhuri A, Bouwman P, Jonkers J. Pulver EM, et al. Cancer Res. 2021 Dec 15;81(24):6171-6182. doi: 10.1158/0008-5472.CAN-21-1415. Epub 2021 Sep 21. Cancer Res. 2021. PMID: 34548335 Free PMC article.

5

In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.

Ruigrok EAM, Tamborino G, de Blois E, Roobol SJ, Verkaik N, De Saint-Hubert M, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: verkaik n. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3627-3638. doi: 10.1007/s00259-022-05821-w. Epub 2022 May 12. Eur J Nucl Med Mol Imaging. 2022. PMID: 35556158 Free PMC article.

6

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment.

Ruigrok EAM, Verkaik NS, de Blois E, de Ridder C, Stuurman D, Roobol SJ, Van Gent DC, de Jong M, Van Weerden WM, Nonnekens J. Ruigrok EAM, et al. Int J Mol Sci. 2022 Jul 21;23(14):8037. doi: 10.3390/ijms23148037. Int J Mol Sci. 2022. PMID: 35887398 Free PMC article.

7

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib.

Feijtel D, Reuvers TGA, van Tuyll-van Serooskerken C, de Ridder CMA, Stuurman DC, de Blois E, Verkaik NS, de Bruijn P, Koolen SLW, de Jong M, Nonnekens J. Feijtel D, et al. Cancers (Basel). 2023 Feb 1;15(3):915. doi: 10.3390/cancers15030915. Cancers (Basel). 2023. PMID: 36765883 Free PMC article.

8

DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivo.

Reuvers TGA, Verkaik NS, Stuurman D, de Ridder C, Groningen MCC, de Blois E, Nonnekens J. Reuvers TGA, et al. Among authors: verkaik ns. Theranostics. 2023 May 21;13(10):3117-3130. doi: 10.7150/thno.82963. eCollection 2023. Theranostics. 2023. PMID: 37351169 Free PMC article.

9

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients.

Ladan MM, Meijer TG, Verkaik NS, de Monye C, Koppert LB, Oomen-de Hoop E, van Deurzen CHM, Kanaar R, Nonnekens J, van Gent DC, Jager A. Ladan MM, et al. Among authors: verkaik ns. NPJ Breast Cancer. 2023 Sep 30;9(1):80. doi: 10.1038/s41523-023-00583-6. NPJ Breast Cancer. 2023. PMID: 37777518 Free PMC article.

10

Defective Artemis nuclease is characterized by coding joints with microhomology in long palindromic-nucleotide stretches.

van der Burg M, Verkaik NS, den Dekker AT, Barendregt BH, Pico-Knijnenburg I, Tezcan I, vanDongen JJ, van Gent DC. van der Burg M, et al. Eur J Immunol. 2007 Dec;37(12):3522-8. doi: 10.1002/eji.200737624. Eur J Immunol. 2007. PMID: 18034425 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page